tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BCRX Stock Latest News

BioCryst Pharmaceuticals’ BCX9930 Study Termination: Implications for Investors
Company AnnouncementsBioCryst Pharmaceuticals’ BCX9930 Study Termination: Implications for Investors
4d ago
BCRX
BioCryst Appoints New CFO to Drive Growth
PremiumCompany Announcements
BioCryst Appoints New CFO to Drive Growth
8d ago
8K
BCRX
BioCryst appoints Babar Ghias as CFO, head of corporate development
PremiumThe Fly
BioCryst appoints Babar Ghias as CFO, head of corporate development
8d ago
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe Fly
BioCryst reports inducement grants under Nasdaq listing rule
12d ago
BCRX
BioCryst price target raised to $15 from $13 at BofA
PremiumThe Fly
BioCryst price target raised to $15 from $13 at BofA
14d ago
BCRX
BioCryst’s Strategic Sale and Debt Retirement Strengthen Financial Position and Justify Buy Rating
PremiumRatingsBioCryst’s Strategic Sale and Debt Retirement Strengthen Financial Position and Justify Buy Rating
14d ago
BCRX
BioCryst Sells BioCryst Ireland to Neopharmed Gentili
Premium
Company Announcements
BioCryst Sells BioCryst Ireland to Neopharmed Gentili
14d ago
8K
BCRX
BioCryst price target raised to $18 from $16 at Wedbush
Premium
The Fly
BioCryst price target raised to $18 from $16 at Wedbush
14d ago
BCRX
BioCryst Sells European ORLADEYO Business for $264M
PremiumCompany Announcements
BioCryst Sells European ORLADEYO Business for $264M
18d ago
8K
BCRX
BioCryst to sell its European ORLADEYO busines to Neopharmed for up to $264M
PremiumThe Fly
BioCryst to sell its European ORLADEYO busines to Neopharmed for up to $264M
18d ago
BCRX
BioCryst expects to end 2027 with $700M in cash
PremiumThe Fly
BioCryst expects to end 2027 with $700M in cash
18d ago
BCRX
FDA Extends BioCryst’s ORLADEYO Review Deadline
PremiumCompany Announcements
FDA Extends BioCryst’s ORLADEYO Review Deadline
20d ago
8K
BCRX
BioCryst Stockholders Approve Stock Incentive Plan Amendment
PremiumCompany AnnouncementsBioCryst Stockholders Approve Stock Incentive Plan Amendment
28d ago
8K
BCRX
BioCryst announces new data on efficacy, safety of ORLADEYO
Premium
The Fly
BioCryst announces new data on efficacy, safety of ORLADEYO
29d ago
BCRX
BioCryst announces INVIMA in Colombia approved ORLADEYO
Premium
The Fly
BioCryst announces INVIMA in Colombia approved ORLADEYO
1M ago
BCRX
BioCryst achieves reimbursement for ORLADEYO across major European countries
PremiumThe Fly
BioCryst achieves reimbursement for ORLADEYO across major European countries
1M ago
BCRX
BioCryst Extends Consulting Agreement with Former CFO
PremiumCompany Announcements
BioCryst Extends Consulting Agreement with Former CFO
1M ago
8K
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe Fly
BioCryst reports inducement grants under Nasdaq listing rule
1M ago
BCRX
BioCryst highlights real-world data on ORLADEYO in HAE attacks
PremiumThe Fly
BioCryst highlights real-world data on ORLADEYO in HAE attacks
2M ago
BCRX
BioCryst presents new real-world evidence on ORLADEYO in severe HAE
PremiumThe FlyBioCryst presents new real-world evidence on ORLADEYO in severe HAE
2M ago
BCRX
BioCryst’s Strategic Advancements and Market Potential: A Buy Rating by Serge Belanger
Premium
Ratings
BioCryst’s Strategic Advancements and Market Potential: A Buy Rating by Serge Belanger
2M ago
BCRX
BioCryst’s ORLADEYO Receives FDA Priority Review
Premium
Company Announcements
BioCryst’s ORLADEYO Receives FDA Priority Review
2M ago
8K
BCRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >